VACCINES DEVELOPMENT AND THE SCIENCE THAT RESPONDS TO HESITANCY: LEARNING ACTIVITIES AND LEARNING OBJECTS
Vaccines_Painting of Ernest Board (1877-1934).png
Κeywords
GENERAL INFORMATION
Title
Vaccines development and the science that responds to hesitancy: Learning Activities and Learning Objects
 Vaccines development and the science that responds to hesitancy: Learning Activities and Learning Objects
Description
Recently, a new virus has spread around the world, which has caused a lot of businesses to shut down and schools to close to limit the spread. Many pharmaceutical companies try to develop a vaccine that passes rigorous approval tests. One vaccine candidate has passed all these tests, but it has a low efficacy rate of around 50%, meaning that a person who is vaccinated is only half as likely to get sick from the real virus, then a person who is not vaccinated. The pharmaceutical company argues that the vaccine should be distributed anyway, so that people can be protected, and life can get back to normality. The government people also agree because they want the economy to improve. On the other hand, public health workers are concerned that if a vaccine that has such low efficacy is distributed, people may relax their other preventative behaviours such as avoiding large social gatherings or wearing masks. They are, particularly, worried because a lot of people have signalled that they are afraid to get vaccinated at all. Should a low efficacy vaccine be released to the public? Students’ Mission Your mission is to investigate the following primary research questions: 1. How do vaccines influence the progress of an epidemic and a pandemic? 2. What are the local community’s perceptions and knowledge concerning immunity and vaccination? 3. Should a low efficacy vaccine be released to the public? (Debate based on the above socio-scientific issue)
 Recently, a new virus has spread around the world, which has caused a lot of businesses to shut down and schools to close to limit the spread. Many pharmaceutical companies try to develop a vaccine that passes rigorous approval tests. One vaccine candidate has passed all these tests, but it has a low efficacy rate of around 50%, meaning that a person who is vaccinated is only half as likely to get sick from the real virus, then a person who is not vaccinated. The pharmaceutical company argues that the vaccine should be distributed anyway, so that people can be protected, and life can get back to normality. The government people also agree because they want the economy to improve. On the other hand, public health workers are concerned that if a vaccine that has such low efficacy is distributed, people may relax their other preventative behaviours such as avoiding large social gatherings or wearing masks. They are, particularly, worried because a lot of people have signalled that they are afraid to get vaccinated at all. Should a low efficacy vaccine be released to the public? Students’ Mission Your mission is to investigate the following primary research questions: 1. How do vaccines influence the progress of an epidemic and a pandemic? 2. What are the local community’s perceptions and knowledge concerning immunity and vaccination? 3. Should a low efficacy vaccine be released to the public? (Debate based on the above socio-scientific issue)
REFERENCE URL
https://photodentro.pafse.eu/handle/8586/416
LEARNER CHARACTERISTICS
Educational level
lower secondary, higher secondary
Τypical age range
From 13 To 16
FUNDING INFORMATION
LEARNING OBJECT
program / project: PAFSE project
PAFSE project
METADATA
program / project: PAFSE project
PAFSE project
CLASSIFICATION
Subject / Topic / Concept
Biology > Human Being and Health > Defence Mechanisms
APPEARS IN COLLECTIONS
Learning Objects
CONTRIBUTION
CONTRIBUTORS
Producer: Andreani Baytelman - University of Cyprus
METADATA CONTRIBUTORS
LEARNING OBJECT / METADATA LICENSING & PUBLISHING
Licensor: Andreani Baytelman, University of Cyprus
Publisher: Andreani Baytelman, University of Cyprus
Has origin: University of Cyprus
Is derivative of: University of Cyprus
TECHNICAL INFORMATION
Format
application/pdf (2.08 MB)
ADDITIONAL INFORMATION
Language
english, english
Original language
english, english
Spoken language
english, english
Subtitles
english, english
IDENTIFIER
PHOTODENTRO
8586/416
LICENSE
lisence icon
Creative Commons Attribution 4.0 International (CC BY 4.0)
More